Form 4: Ryan Specialty Executive Receives Stock Option Grant

Brendan Martin Mulshine, Co-President and CRO of Ryan Specialty Holdings, Inc., was granted 33,715 stock options.

Summary

• Brendan Martin Mulshine, Co-President and CRO of Ryan Specialty Holdings, Inc. (RYAN), received a grant of 33,715 stock options.
• The options have an exercise price of $29.66 per share.
• The grant date for these options is May 5, 2026.
• The options are set to expire on May 5, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative disclosure regarding executive compensation that does not signal a change in company fundamentals.

Positives

• The grant aligns executive interests with long-term shareholder value through equity-based compensation.
• The vesting schedule is back-weighted, encouraging long-term retention of key leadership.

Negatives

• The grant results in potential future dilution for existing shareholders upon exercise.

Risks

• Market volatility could impact the value of the options relative to the exercise price.
• The long-term vesting schedule (2029-2031) creates dependency on the executive's continued tenure.

Future Outlook

The options vest in equal installments on July 1, 2029, 2030, and 2031, indicating a long-term incentive structure for the executive.

Management Comments

• The grant was approved by the compensation and governance committee of the board of the Issuer for the purposes of rule 16(b)(3).

Industry Context

StockSavvy.ai notes that equity grants for C-suite executives in the insurance brokerage sector are standard practice to ensure alignment with long-term performance goals and retention in a competitive talent market.

Comparison to Industry Standards

• The use of multi-year vesting schedules is consistent with industry standards for executive compensation at large-cap financial services firms like Marsh McLennan or Aon.
• The exercise price set at the market value on the grant date is standard regulatory practice.

Corporate Governance

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual exercise of these options.

Next Steps

• Vesting of options beginning July 1, 2029.

Key Dates

Keywords

Ryan Specialty, RYAN, Form 4, Insider Trading, Stock Options, Executive Compensation